APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Acne Prescription Medication

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Acne Prescription Medication Market Outlook and Growth Opportunities 2026

Report ID 17395988042 January 2026198 pages

Choose your research edition.

Industry ResearchAcne Prescription Medication Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Acne Prescription Medication Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Acne Prescription Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acne Prescription Medication Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Acne Prescription Medication Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Acne Prescription Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Acne Prescription Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Acne Prescription Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acne Prescription Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Acne Prescription Medication market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Acne Prescription Medication market include Almirall, Bausch Health, Galderma, HUAPONT, Lion, Mayne Pharma, Sine Pharma, Sun Pharma and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Acne Prescription Medication market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Acne Prescription Medication and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Acne Prescription Medication revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Acne Prescription Medication market.

Acne Prescription Medication Segment by Company

Almirall

Bausch Health

Galderma

HUAPONT

Lion

Mayne Pharma

Sine Pharma

Sun Pharma

GlaxoSmithKline

Mylan

Teva

Acne Prescription Medication Segment by Type

Topical

Oral

Acne Prescription Medication Segment by Application

Inflammatory Acne

Non-inflammatory Acne

Acne Prescription Medication Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Acne Prescription Medication status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Acne Prescription Medication key companies, revenue, market share, and recent developments.

3. To split the Acne Prescription Medication breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Acne Prescription Medication market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Acne Prescription Medication significant trends, drivers, influence factors in global and regions.

6. To analyze Acne Prescription Medication competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acne Prescription Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acne Prescription Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acne Prescription Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acne Prescription Medication industry.

Chapter 3: Detailed analysis of Acne Prescription Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Acne Prescription Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Acne Prescription Medication in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Acne Prescription Medication Industry Trends Table 2. Acne Prescription Medication Industry Drivers Table 3. Acne Prescription Medication Industry Opportunities and Challenges Table 4. Acne Prescription Medication Industry Restraints Table 5. Global Acne Prescription Medication Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Acne Prescription Medication Revenue Share by Company (2021-2026) Table 7. Global Acne Prescription Medication Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Acne Prescription Medication Key Company Manufacturing Base & Headquarters Table 9. Global Acne Prescription Medication Company, Product Type & Application Table 10. Global Acne Prescription Medication Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Acne Prescription Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Topical Table 15. Significant Companies of Oral Table 16. Global Acne Prescription Medication Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Acne Prescription Medication Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Acne Prescription Medication Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Acne Prescription Medication Sales Value Share by Type (2021-2026) Table 20. Global Acne Prescription Medication Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Inflammatory Acne Table 22. Significant Companies of Non-inflammatory Acne Table 23. Global Acne Prescription Medication Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Acne Prescription Medication Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Acne Prescription Medication Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Acne Prescription Medication Sales Value Share by Application (2021-2026) Table 27. Global Acne Prescription Medication Sales Value Share by Application (2027-2032) Table 28. Global Acne Prescription Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Acne Prescription Medication Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Acne Prescription Medication Sales Value Share by Region (2021-2026) Table 31. Global Acne Prescription Medication Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Acne Prescription Medication Sales Value Share by Region (2027-2032) Table 33. Global Acne Prescription Medication Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Acne Prescription Medication Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Acne Prescription Medication Sales Value Market Share by Country (2021-2026) Table 36. Global Acne Prescription Medication Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Acne Prescription Medication Sales Value Market Share by Country (2027-2032) Table 38. Almirall Company Information Table 39. Almirall Business Overview Table 40. Almirall Acne Prescription Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Almirall Acne Prescription Medication Product Portfolio Table 42. Almirall Recent Development Table 43. Bausch Health Company Information Table 44. Bausch Health Business Overview Table 45. Bausch Health Acne Prescription Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Bausch Health Acne Prescription Medication Product Portfolio Table 47. Bausch Health Recent Development Table 48. Galderma Company Information Table 49. Galderma Business Overview Table 50. Galderma Acne Prescription Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Galderma Acne Prescription Medication Product Portfolio Table 52. Galderma Recent Development Table 53. HUAPONT Company Information Table 54. HUAPONT Business Overview Table 55. HUAPONT Acne Prescription Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. HUAPONT Acne Prescription Medication Product Portfolio Table 57. HUAPONT Recent Development Table 58. Lion Company Information Table 59. Lion Business Overview Table 60. Lion Acne Prescription Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Lion Acne Prescription Medication Product Portfolio Table 62. Lion Recent Development Table 63. Mayne Pharma Company Information Table 64. Mayne Pharma Business Overview Table 65. Mayne Pharma Acne Prescription Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Mayne Pharma Acne Prescription Medication Product Portfolio Table 67. Mayne Pharma Recent Development Table 68. Sine Pharma Company Information Table 69. Sine Pharma Business Overview Table 70. Sine Pharma Acne Prescription Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sine Pharma Acne Prescription Medication Product Portfolio Table 72. Sine Pharma Recent Development Table 73. Sun Pharma Company Information Table 74. Sun Pharma Business Overview Table 75. Sun Pharma Acne Prescription Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sun Pharma Acne Prescription Medication Product Portfolio Table 77. Sun Pharma Recent Development Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Acne Prescription Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Acne Prescription Medication Product Portfolio Table 82. GlaxoSmithKline Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Acne Prescription Medication Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Mylan Acne Prescription Medication Product Portfolio Table 87. Mylan Recent Development Table 88. Teva Company Information Table 89. Teva Business Overview Table 90. Teva Acne Prescription Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Teva Acne Prescription Medication Product Portfolio Table 92. Teva Recent Development Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Acne Prescription Medication Product Image Figure 2. Global Acne Prescription Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acne Prescription Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Acne Prescription Medication Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Topical Image Figure 8. Oral Image Figure 9. Global Acne Prescription Medication Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Acne Prescription Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Acne Prescription Medication Sales Value Share by Type (2021-2032) Figure 12. Inflammatory Acne Image Figure 13. Non-inflammatory Acne Image Figure 14. Global Acne Prescription Medication Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Acne Prescription Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Acne Prescription Medication Sales Value Share by Application (2021-2032) Figure 17. Global Acne Prescription Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Acne Prescription Medication Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Acne Prescription Medication Sales Value (2021-2032) & (US$ Million) Figure 20. North America Acne Prescription Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Acne Prescription Medication Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Acne Prescription Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Acne Prescription Medication Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Acne Prescription Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Acne Prescription Medication Sales Value (2021-2032) & (US$ Million) Figure 26. South America Acne Prescription Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Acne Prescription Medication Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Acne Prescription Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Acne Prescription Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Topical
  • Oral
Applications
  • Inflammatory Acne
  • Non-inflammatory Acne
Companies covered
  • Almirall
  • Bausch Health
  • Galderma
  • HUAPONT
  • Lion
  • Mayne Pharma
  • Sine Pharma
  • Sun Pharma
  • GlaxoSmithKline
  • Mylan
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Acne Prescription Medication Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Acne Prescription Medication Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Acne Prescription Medication Market Dynamics
  1. 2.1 Acne Prescription Medication Industry Trends
  2. 2.2 Acne Prescription Medication Industry Drivers
  3. 2.3 Acne Prescription Medication Industry Opportunities and Challenges
  4. 2.4 Acne Prescription Medication Industry Restraints
3 Acne Prescription Medication Market by Company
  1. 3.1 Global Acne Prescription Medication Company Revenue Ranking in 2025
  2. 3.2 Global Acne Prescription Medication Revenue by Company (2021-2026)
  3. 3.3 Global Acne Prescription Medication Company Ranking (2024-2026)
  4. 3.4 Global Acne Prescription Medication Company Manufacturing Base and Headquarters
  5. 3.5 Global Acne Prescription Medication Company Product Type and Application
  6. 3.6 Global Acne Prescription Medication Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Acne Prescription Medication Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Acne Prescription Medication Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Acne Prescription Medication Market by Type
  1. 4.1 Acne Prescription Medication Type Introduction
  2. 4.1.1 Topical
  3. 4.1.2 Oral
  4. 4.2 Global Acne Prescription Medication Sales Value by Type
  5. 4.2.1 Global Acne Prescription Medication Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Acne Prescription Medication Sales Value by Type (2021-2032)
  7. 4.2.3 Global Acne Prescription Medication Sales Value Share by Type (2021-2032)
5 Acne Prescription Medication Market by Application
  1. 5.1 Acne Prescription Medication Application Introduction
  2. 5.1.1 Inflammatory Acne
  3. 5.1.2 Non-inflammatory Acne
  4. 5.2 Global Acne Prescription Medication Sales Value by Application
  5. 5.2.1 Global Acne Prescription Medication Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Acne Prescription Medication Sales Value by Application (2021-2032)
  7. 5.2.3 Global Acne Prescription Medication Sales Value Share by Application (2021-2032)
6 Acne Prescription Medication Regional Value Analysis
  1. 6.1 Global Acne Prescription Medication Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Acne Prescription Medication Sales Value by Region (2021-2032)
  3. 6.2.1 Global Acne Prescription Medication Sales Value by Region: 2021-2026
  4. 6.2.2 Global Acne Prescription Medication Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Acne Prescription Medication Sales Value (2021-2032)
  7. 6.3.2 North America Acne Prescription Medication Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Acne Prescription Medication Sales Value (2021-2032)
  10. 6.4.2 Europe Acne Prescription Medication Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Acne Prescription Medication Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Acne Prescription Medication Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Acne Prescription Medication Sales Value (2021-2032)
  16. 6.6.2 South America Acne Prescription Medication Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Acne Prescription Medication Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Acne Prescription Medication Sales Value Share by Country, 2025 VS 2032
7 Acne Prescription Medication Country-level Value Analysis
  1. 7.1 Global Acne Prescription Medication Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Acne Prescription Medication Sales Value by Country (2021-2032)
  3. 7.2.1 Global Acne Prescription Medication Sales Value by Country (2021-2026)
  4. 7.2.2 Global Acne Prescription Medication Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Acne Prescription Medication Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Acne Prescription Medication Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Acne Prescription Medication Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Almirall
  2. 8.1.1 Almirall Company Information
  3. 8.1.2 Almirall Business Overview
  4. 8.1.3 Almirall Acne Prescription Medication Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Almirall Acne Prescription Medication Product Portfolio
  6. 8.1.5 Almirall Recent Developments
  7. 8.2 Bausch Health
  8. 8.2.1 Bausch Health Company Information
  9. 8.2.2 Bausch Health Business Overview
  10. 8.2.3 Bausch Health Acne Prescription Medication Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bausch Health Acne Prescription Medication Product Portfolio
  12. 8.2.5 Bausch Health Recent Developments
  13. 8.3 Galderma
  14. 8.3.1 Galderma Company Information
  15. 8.3.2 Galderma Business Overview
  16. 8.3.3 Galderma Acne Prescription Medication Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Galderma Acne Prescription Medication Product Portfolio
  18. 8.3.5 Galderma Recent Developments
  19. 8.4 HUAPONT
  20. 8.4.1 HUAPONT Company Information
  21. 8.4.2 HUAPONT Business Overview
  22. 8.4.3 HUAPONT Acne Prescription Medication Revenue and Gross Margin (2021-2026)
  23. 8.4.4 HUAPONT Acne Prescription Medication Product Portfolio
  24. 8.4.5 HUAPONT Recent Developments
  25. 8.5 Lion
  26. 8.5.1 Lion Company Information
  27. 8.5.2 Lion Business Overview
  28. 8.5.3 Lion Acne Prescription Medication Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lion Acne Prescription Medication Product Portfolio
  30. 8.5.5 Lion Recent Developments
  31. 8.6 Mayne Pharma
  32. 8.6.1 Mayne Pharma Company Information
  33. 8.6.2 Mayne Pharma Business Overview
  34. 8.6.3 Mayne Pharma Acne Prescription Medication Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mayne Pharma Acne Prescription Medication Product Portfolio
  36. 8.6.5 Mayne Pharma Recent Developments
  37. 8.7 Sine Pharma
  38. 8.7.1 Sine Pharma Company Information
  39. 8.7.2 Sine Pharma Business Overview
  40. 8.7.3 Sine Pharma Acne Prescription Medication Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sine Pharma Acne Prescription Medication Product Portfolio
  42. 8.7.5 Sine Pharma Recent Developments
  43. 8.8 Sun Pharma
  44. 8.8.1 Sun Pharma Company Information
  45. 8.8.2 Sun Pharma Business Overview
  46. 8.8.3 Sun Pharma Acne Prescription Medication Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharma Acne Prescription Medication Product Portfolio
  48. 8.8.5 Sun Pharma Recent Developments
  49. 8.9 GlaxoSmithKline
  50. 8.9.1 GlaxoSmithKline Company Information
  51. 8.9.2 GlaxoSmithKline Business Overview
  52. 8.9.3 GlaxoSmithKline Acne Prescription Medication Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GlaxoSmithKline Acne Prescription Medication Product Portfolio
  54. 8.9.5 GlaxoSmithKline Recent Developments
  55. 8.10 Mylan
  56. 8.10.1 Mylan Company Information
  57. 8.10.2 Mylan Business Overview
  58. 8.10.3 Mylan Acne Prescription Medication Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mylan Acne Prescription Medication Product Portfolio
  60. 8.10.5 Mylan Recent Developments
  61. 8.11 Teva
  62. 8.11.1 Teva Company Information
  63. 8.11.2 Teva Business Overview
  64. 8.11.3 Teva Acne Prescription Medication Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Teva Acne Prescription Medication Product Portfolio
  66. 8.11.5 Teva Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst